**Author details**

Ido Didi Fabian1 \*, Faisal Al Qahtani<sup>2</sup> and Covadonga Bascaran1

1 International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK

2 King Saud University, Riyadh, Saudi Arabia

\*Address all correspondence to: didi@didifabian.com

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**23**

*Epidemiological and Genetic Considerations in Retinoblastoma*

[8] Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975-2004. The British Journal of Ophthalmology. 2009;**93**:21-23. DOI:

[9] Seregard S, Lundell G, Svedberg H, et al. Incidence of retinoblastoma from 1958 to 1998 in Northern Europe. Advantages of birth cohort analysis. Ophthalmology. 2004;**111**:1228-1232. DOI: 10.1016/j.ophtha.2003.10.023

[10] United Nations, Department of Economic and Social Affairs Population Division. World Population Prospects the 2017 Revision. Vol. I: Comprehensive Tables (ST/ESA/SER.A/399). 2017. Available from: https://esa.un.org/unpd/ wpp/Publications/Files/WPP2017\_ Volume-I\_Comprehensive-Tables.pdf [Accessed: 29 November 2017]

[11] MacCarthy A, Birch JM, Draper GJ, et al. Retinoblastoma: Treatment and survival in Great Britain 1963 to 2002. The British Journal of Ophthalmology.

[12] International Agency for Research on Cancer. International Incidence of Childhood Cancer International Agency for Research on Cancer. Lyon, France. 1998. Available from: http://iicc.iarc.fr/

[13] Sitorus RS, Moll AC, Suhardjono S,

[14] Tamboli A, Podgor MJ, Horm JW. The incidence of retinoblastoma in the United States: 1974 through 1985. Archives of Ophthalmology (Chicago, III: 1960). 1990;**108**:128-132. Available from: http://www.ncbi.nlm.nih.

et al. The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common. Ophthalmic Genetics. 2009;**30**:31-36. DOI: 10.1080/13816810802464320

2009;**93**:38-39. DOI: 10.1136/

bjo.2008.139626

results/

10.1136/bjo.2008.138750

*DOI: http://dx.doi.org/10.5772/intechopen.86811*

[1] Kivelä T. The epidemiological challenge of the most frequent eye cancer: Retinoblastoma, an issue of birth and death. The British Journal of Ophthalmology. 2009;**93**:1129-1131. DOI: 10.1136/bjo.2008.150292

[2] MacCarthy A, Birch JM, Draper GJ, et al. Retinoblastoma in Great Britain 1963-2002. The British Journal of Ophthalmology. 2009;**93**:33-37. DOI:

[3] Dimaras H, Corson TW, Cobrinik D, et al. Retinoblastoma. Nature Reviews. Disease Primers. 2015;**1**:15021. DOI:

[4] Smith LM, Donaldson SS, Egbert PR,

[5] Abramson DH, Ellsworth RM, Kitchin FD, et al. Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced? Ophthalmology. 1984;**91**:1351-1355. Available from: http:// www.ncbi.nlm.nih.gov/pubmed/6595610

[6] Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblastoma. British Journal of Cancer. 1986;**53**:661-671. Available from: http://www.ncbi.nlm.nih. gov/pubmed/3718823 [Accessed: 27

[7] Kivelä T. Trilateral retinoblastoma:

retinoblastoma associated with primary ectopic intracranial retinoblastoma. Journal of Clinical Oncology. 1999;**17**:1829-1837. DOI: 10.1200/

A meta-analysis of hereditary

[Accessed: 27 February 2019]

et al. Aggressive management of second primary tumors in survivors of hereditary retinoblastoma. International Journal of Radiation Oncology, Biology, Physics. 1989;**17**:499-505. Available from: http://www.ncbi.nlm.nih. gov/pubmed/2777644 [Accessed: 27

10.1136/bjo.2008.139618

10.1038/nrdp.2015.21

February 2019]

February 2019]

JCO.1999.17.6.1829

**References**

*Epidemiological and Genetic Considerations in Retinoblastoma DOI: http://dx.doi.org/10.5772/intechopen.86811*
